The monopoly market of pharmaceutical companies has many problems, including market control, price manipulation, innovation restriction, and unequal medical resources. This monopoly leads to excessively high drug prices that prevent many patients from getting the treatment they need, which in turn exacerbates the unequal distribution of healthcare resources. At the same time, pharmaceutical companies abuse patent rights to limit competition, limiting the introduction of new drugs and innovation. Addressing these issues requires concerted efforts by governments and the international community to strengthen regulation, encourage competition, develop reasonable price control policies, and promote equitable distribution of medical resources to ensure that patients have access to safe, effective, and affordable drug treatment.

The petition calls for generic competition in the market, new legislation to reduce patent protection, and stronger government oversight of prices.
1.   The petition clearly describes the problems caused by drug companies' monopolized markets, including their negative impact on consumers, the health system, and the economy.
2.   Provide relevant evidence and data to prove the importance and seriousness of the matter.
3.   Proposing solutions that patients can accept may include regulatory measures, competition policy, or other actions.
4.   Seek support from other stakeholders or organizations to increase the impact and credibility of the petition.
5.   After submitting the petition, follow up and communicate with government agencies to understand their response and progress to the issues and solutions you have raised.